THE RELATIONSHIP BETWEEN CLINICAL SIGNS AND HYPERCOAGULABLE STATE IN TOXEMIA OF PREGNANCY

被引:37
作者
TERAO, T
MAKI, M
IKENOUE, T
GOTOH, K
MURATA, M
IWASAKI, H
SHIBATA, J
NAKABAYASHI, M
MURAOKA, M
TAKEDA, Y
SAKAMOTO, S
KOBAYASHI, T
IMAI, N
ODA, H
SAMESHIMA, H
机构
[1] AKITA UNIV, SCH MED, DEPT OBSTET & GYNECOL, AKITA 010, JAPAN
[2] KAGOSHIMA MUNICIPAL HOSP, DEPT OBSTET & GYNECOL, KAGOSHIMA, JAPAN
[3] UNIV TSUKUBA, SCH MED, DEPT OBSTET & GYNECOL, SAKURA, IBARAKI 30031, JAPAN
[4] TOKYO WOMENS MED COLL, DEPT OBSTET & GYNECOL, TOKYO 162, JAPAN
[5] HANDA MUNICIPAL HOSP, DEPT OBSTET & GYNECOL, HANDA, JAPAN
关键词
TOXEMIA OF PREGNANCY; PREECLAMPSIA; THROMBIN-ANTITHROMBIN-III COMPLEX; ALPHA-2-ANTIPLASMIN-PLASMIN COMPLEX; D-DIMER FDP; ANTITHROMBIN-III; CANONICAL CORRELATION ANALYSIS; HEPARIN;
D O I
10.1159/000293106
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The hypercoagulable state in patients with toxemia of pregnancy was investigated in comparison with normal pregnant women using new coagulation parameters, mainly thrombin-antithrombin III (TAT) complexes, alpha-2-antiplasmin-plasmin complexes (PIP), and D-dimer FDP. When the patients were categorized by the classification of the WHO Study Group (1985), significant increases of TAT complexes and alpha-2-PIP complexes with decreases of the ATIII level were observed in the groups with preeclampsia and severe gestational hypertensive disease as compared to normal pregnant women. A significant increase of D-dimer FDP was observed in a group with severe gestational hypertensive disease. Additionally, the relationship between clinical signs and the hypercoagulable state in the patients was analyzed using canonical correlation analysis as a multivariate analysis. The clinical signs and coagulation parameters had a significantly high correlation of lambda-1 = 0.7219, p < 0.01. The results showed that clinical signs were associated with simultaneous coagulation abnormalities. The indices obtained from the results of canonical correlation analysis, which were called the clinical index and the coagulation index, should be useful in evaluating the efficacy of anticoagulation therapy.
引用
收藏
页码:74 / 85
页数:12
相关论文
共 49 条
[1]  
ALES KL, 1986, CLIN EXP HYPERTENS B, V2, P203
[2]   ABILITY OF KALLIKREIN TO GENERATE ANGIOTENSIN-II-LIKE PRESSOR SUBSTANCE AND A PROPOSED KININ-TENSIN ENZYME-SYSTEM [J].
ARAKAWA, K ;
MARUTA, H .
NATURE, 1980, 288 (5792) :705-706
[3]  
AZNAR J, 1986, THROMB HAEMOSTASIS, V55, P314
[4]  
BAUER KA, 1987, BLOOD, V70, P343
[5]  
BOER K, 1989, AM J OBSTET GYNECOL, V160, P95
[6]  
BOER K, 1988, AM J OBSTET GYNECOL, V158, P518
[7]   ISOLATION AND CHARACTERIZATION OF PLACENTAL PROTEIN-PP5 [J].
BOHN, H ;
WINCKLER, W .
ARCHIV FUR GYNAKOLOGIE, 1977, 223 (03) :179-186
[8]   COAGULATION AND FIBRINOLYTIC SYSTEMS IN PRE-ECLAMPSIA AND ECLAMPSIA [J].
BONNAR, J ;
MCNICOL, GP ;
DOUGLAS, AS .
BRITISH MEDICAL JOURNAL, 1971, 2 (5752) :12-&
[9]   COAGULATION STUDIES IN HYPERTENSIVE TOXEMIAS OF PREGNANCY [J].
DAVIDSON, EC ;
PHILLIPS, LL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1972, 113 (07) :905-&
[10]  
DERKX FHM, 1979, CLIN SCI, V57, P89